ArticleOpen life sciences2025

Battling COVID-19 leveraging nanobiotechnology: Gold and silver nanoparticle-B-escin conjugates as SARS-CoV-2 inhibitors.

Ilyes Zatla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.